EPCR deficiency or function-blocking antibody protects against joint bleeding–induced pathology in hemophilia mice

類似資料

• Increased Accumulation and Retention of rhFVIIa (eptacog beta) in Knee Joints of Hemophilia A Mice Compared to Wild-Type Mice
  著者:: Magisetty, Jhansi, 等
  出版事項: (2019)
• Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action
  著者:: Keshava, Shiva, 等
  出版事項: (2017)
• Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1
  著者:: Kondreddy, Vijay, 等
  出版事項: (2018)
• Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms
  著者:: Keshava, Shiva, 等
  出版事項: (2020)
• Blockade of endothelial cell protein C receptor augments factor VIIa hemostatic effect in hemophilia treatment
  著者:: Sundaram, Jagan, 等
  出版事項: (2014)